NEW YORK, Oct. 31, 2023 /PRNewswire/ — The Premature Ejaculation (PE) Treatment Market size is expected to grow by USD 1.45 billion, accelerating at a CAGR of 8.78% during the forecast period, according to Technavio market analysis. Companies are implementing various strategies like forming partnerships, mergers, expanding into new areas, and launching new products to improve their… Continue reading Premature Ejaculation (PE) Treatment Market size to grow by USD 1.45 billion from 2023-2028| A. Menarini Industrie Farmaceutiche Riunite Srl, Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Ltd., and more among the key companies in the market – Technavio
Category: Newswire
Project Logistics Market size to increase by USD 59.41 billion during 2023-2028- Technavio
NEW YORK, Oct. 31, 2023 /PRNewswire/ — The Project Logistics Market size is expected to grow by USD 59.41 billion, accelerating at a CAGR of almost 4.3% during the forecast period. The market is experiencing significant growth driven by the increasing demand for project logistics within the automotive industry. The automotive supply chain operates on a global scale, requiring seamless… Continue reading Project Logistics Market size to increase by USD 59.41 billion during 2023-2028- Technavio
Global Extracorporeal CO2 Removal Devices Market Report 2023-2030 with Competitive Analysis of Medtronic, Getinge, Xenios, ALung Technologies, ESTOR S.P.A., Medica, & Aferetica
DUBLIN, Oct. 31, 2023 /PRNewswire/ — The “Extracorporeal CO2 Removal Devices Market Size, Share & Trends Analysis Report By Product (Extracorporeal CO2 Machines, Disposables, Others), By Application, By Access, By End-use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global extracorporeal CO2 removal devices market size is estimated to reach… Continue reading Global Extracorporeal CO2 Removal Devices Market Report 2023-2030 with Competitive Analysis of Medtronic, Getinge, Xenios, ALung Technologies, ESTOR S.P.A., Medica, & Aferetica
Designing Chips with CHIPS: West Coast Pre-Silicon Summit to Convene Industry Leaders in San Diego
SAN DIEGO, Oct. 31, 2023 /PRNewswire/ — On 3 November, 2023, the “Designing Chips with CHIPS: West Coast Pre-Silicon Summit” will gather influential minds in the chip design and packaging industry, along with key government policy makers, for a one-day, in-person summit at Irwin M Jacobs Qualcomm Hall in Qualcomm Headquarters, San Diego, California. This… Continue reading Designing Chips with CHIPS: West Coast Pre-Silicon Summit to Convene Industry Leaders in San Diego
SANMINA CORPORATION INVITES YOU TO JOIN ITS FOURTH QUARTER AND FISCAL YEAR 2023 EARNINGS CONFERENCE CALL
SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ — Sanmina Corporation (NASDAQ: SANM) announced today that it will host its fourth quarter and fiscal year 2023 earnings conference call on Monday, November 6, 2023 at 4:30 PM ET. The live webcast presentation and supporting materials will be available on the Sanmina Investor Relations website located at… Continue reading SANMINA CORPORATION INVITES YOU TO JOIN ITS FOURTH QUARTER AND FISCAL YEAR 2023 EARNINGS CONFERENCE CALL
Hefty Seed Company choisit la technologie brevetée BIO-CAPSULETM de Meristem
« … un partenariat extrêmement intéressant pour notre clientèle… » BALTIC, Dakota du Sud et COLUMBUS, Ohio, 31 octobre 2023 /PRNewswire/ — Meristem Crop Performance Group, LLC (www.MeristemAg.com) et Hefty Seed Company (www.HeftySeed.com) ont annoncé aujourd’hui la conclusion d’une alliance stratégique et d’une entente d’approvisionnement visant à augmenter les retombées des produits biologiques bénéfiques sur la production… Continue reading Hefty Seed Company choisit la technologie brevetée BIO-CAPSULETM de Meristem
Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
DUBLIN, Oct. 31, 2023 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced that the Registration Statement on Form 10, as amended (Form 10), filed by Mural Oncology plc (Mural Oncology) was declared effective by the U.S. Securities and Exchange Commission (SEC). This Form 10 describes Alkermes’ planned separation of its oncology business into Mural Oncology,… Continue reading Alkermes Announces Effectiveness of Mural Oncology Form 10 Registration Statement
Breast cancer doesn’t end with October: Methodist Le Bonheur Healthcare takes the guesswork out of deciding when to get a mammogram
MEMPHIS, Tenn., Oct. 31, 2023 /PRNewswire/ — Methodist Le Bonheur Healthcare speaks with a surgical oncologist about the best age to begin routine breast cancer mammogram screenings. Ryland Gore, M.D., breast surgical oncologist with the Methodist Cancer Institute says, “At what age to start screening usually depends on a woman’s personal risk factors and family… Continue reading Breast cancer doesn’t end with October: Methodist Le Bonheur Healthcare takes the guesswork out of deciding when to get a mammogram
BZAM Ltd. & 4C LABS conclude strategic distribution agreement for the UK market
VANCOUVER, BC, TORONTO and LONDON, Oct. 31, 2023 /PRNewswire/ – BZAM Ltd. (the “Company” or “BZAM”) (CSE: BZAM) (US-OTC: BZAMF), is pleased to announce that its subsidiary, The Green Organic Dutchman Ltd. (collectively the “Company”) completed its first shipment of Canadian certified organic, EU GMP medical cannabis to the UK on October 25, 2023. The Company is… Continue reading BZAM Ltd. & 4C LABS conclude strategic distribution agreement for the UK market
EnLink Midstream Reports Third Quarter 2023 Results
DALLAS, Oct. 31, 2023 /PRNewswire/ — EnLink Midstream, LLC (NYSE: ENLC) (EnLink) reported financial results for the third quarter of 2023. Highlights Reported net income of $65.8 million and net cash provided by operating activities of $274.2 million for the third quarter of 2023. Generated adjusted EBITDA, net to EnLink, of $341.9 million for the third… Continue reading EnLink Midstream Reports Third Quarter 2023 Results